A systematic review and meta-analysis of the literature included 20 cases of patients with myeloproliferative neoplasms with transformation to the leukemic phase who were carriers of the BCR::FGFR1 fusion t(8;22) (p11;q11). Here, FGFR1 is linked to myeloproliferative disorder.